文献速递肺外科

复杂袖式肺叶切除术与常规肺叶切除术治疗肺癌的手术结局相当

Complex sleeve lobectomy has the same surgical outcome when compared with conventional lobectomy in patients with lung cancer.
PubMed 文献 · Eur J Cardiothorac Surg · 2020-01-01

该回顾性研究比较了2000至2015年间568例开放常规肺叶切除术(CL)与187例袖式肺叶切除术(SL)患者,其中复杂SL 81例。结果显示复杂SL组虽更多患者合并COPD、接受新辅助治疗、分期更晚且术前FEV1更低,但总体手术死亡率、术后并发症及5年生存率与CL组无显著差异。

要点

  • 复杂袖式肺叶切除术的手术死亡率与常规肺叶切除术相当(均为2.8%)。
  • 复杂SL组术后并发症和肺部并发症发生率与CL组无显著差异。
  • 复杂SL组5年生存率56.2%,与CL组57.1%相当(P=0.888)。

核心结论

  • 复杂袖式肺叶切除术的手术结局与常规肺叶切除术相当。
  • 尽管复杂SL组更多患者为晚期NSCLC、术前FEV1低且合并COPD,其结局仍与CL组可比。

研究设计与样本

  • 回顾性分析2000至2015年间568例开放常规肺叶切除术(仅切除1个肺叶)和187例袖式肺叶切除术患者。
  • SL组分为标准SL(支气管袖式,n=106)和复杂SL(n=81),复杂SL包括支气管血管袖式(n=40)、血管袖式(n=26)、非典型支气管成形联合切除超过1个肺叶(n=12)及支气管袖式联合胸壁切除(n=3)。

主要发现

  • 复杂SL组与CL组相比,COPD比例(25.9% vs 12.5%,P=0.001)、新辅助治疗比例(39.5% vs 12.0%,P<0.001)、晚期NSCLC比例(53.2% vs 33.1%,P=0.001)更高,术前FEV1更低(77.2% vs 84.3%,P=0.004)。
  • 总体手术死亡率(住院或30天)为2.6%(n=20),CL组为2.8%,复杂SL组为2.8%。
  • 术后并发症发生率CL组34.9%,复杂SL组39.5%(P=0.413);肺部并发症率CL组24.1%,复杂SL组27.2%(P=0.552)。
  • 5年生存率CL组57.1%,复杂SL组56.2%(P=0.888)。
  • 多因素分析显示TNM分期(P<0.001)和N状态(P<0.001)是生存的显著独立不良预后因素。

临床怎么用

  • 对于需要行复杂袖式肺叶切除术的肺癌患者,其手术结局与常规肺叶切除术相当,可考虑作为合适患者的手术选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: No significant data are available to assess whether complex sleeve lobectomy (complex-SL) can be considered comparable to conventional lobectomy (CL) in terms of surgical outcome. The purpose of this study was to compare surgical and oncological outcomes of complex-SL with CL in patients with lung cancer. METHODS: Between 2000 and 2015, a total of 568 patients who underwent open CL (defined as resection of only 1 lobe) and 187 patients who underwent SL were analysed. The SL group was divided into 2 subgroups: standard-SL (bronchial SL, n = 106) and complex-SL (n = 81) (defined as bronchial sleeve resection together with another surgical intervention: bronchovascular SL, n = 40; vascular SL, n = 26; atypical bronchoplasty with resection of more than 1 lobe, n = 12; bronchial SL + chest wall resection, n = 3). RESULTS: The complex-SL group had more patients with chronic obstructive pulmonary disease (COPD) (25.9% vs 12.5%, P = 0.001), neoadjuvant treatment (39.5% vs 12.0%, P < 0.001), advanced-stage non-small-cell lung cancer (53.2% vs 33.1%, P = 0.001) and low preoperative forced expiratory volume in 1 s (77.2% vs 84.3%, P = 0.004) than the CL group. The overall surgical mortality (in-hospital or 30-day) was 2.6% (n = 20); it was 2.8% for CL and 2.8% for complex-SL. Postoperative complications occurred in 34.9% of the CL group and 39.5% of the complex-SL group (P = 0.413). The pulmonary complication rate was similar between the groups (24.1% for CL, 27.2% for complex-SL, P = 0.552). The 5-year survival in the CL group was 57.1%, and in the complex-SL group it was 56.2% (P = 0.888). Multivariate analysis showed that TNM stage (P < 0.001) and N status (P < 0.001) were significant and independent negative prognostic factors for survival. CONCLUSIONS: Complex-SL had a comparable outcome to CL, although the complex-SL group had more patients with advanced-stage NSCLC, low preoperative forced expiratory volume in 1 s and COPD.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Inci I, Benker M, Çitak N, et al. Complex sleeve lobectomy has the same surgical outcome when compared with conventional lobectomy in patients with lung cancer. Eur J Cardiothorac Surg. 2020. PMID: 31919516. doi:10.1093/ejcts/ezz357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。